Status | Study |
Not yet recruiting |
Study Name: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor Condition: Functional Pancreatic Neuroendocrine Tumor Malignant Somatostatinoma Date: 2016-07-10 Interventions: Drug: Capecitabine Given PO |
Recruiting |
Study Name: Natural History Study of Children and Young Adults With Medullary Thyroid Cancer Condition: Medullary Thyroid Carcer Date: 2012-08-07 |
Active, not recruiting |
Study Name: Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer Condition: Medullary Thyroid Carcinoma Multiple Endocrine Neoplasia Type 2A Date: 2007-08-08 Interventions: Drug: Vandetanib once daily continuously (28 day cycles) |